Search at Vanderbilt-Ingram Cancer Center

1221 results found

Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)

Relevance: 1

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Relevance: 1

Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study

Relevance: 1

Expanded Access Protocol Using 131I-MIBG

Relevance: 1

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

Relevance: 1

Enhanced Recovery After Surgery in Extremity Sarcoma

Relevance: 1

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

Relevance: 1

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Relevance: 1

Imaging Biomarkers of Lymphatic Dysfunction

Relevance: 1

Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)

Relevance: 1